Journal Information
Vol. 33. Issue. 4.July 2013
Pages 443-622
Vol. 33. Issue. 4.July 2013
Pages 443-622
DOI: 10.3265/Nefrologia.pre2013.Feb.11847
Full text access
Severe dysfunction of pacemaker due to hyperkalaemia
Disfunción severa de marcapasos por hiperpotasemia
Visits
4604
Diana Faura, Pere Torguet-Escudera, Martí Vallès-Pratsa
a Servicio de Nefrolog??a, Hospital Universitari Doctor Josep Trueta, Girona
This item has received
4604
Visits
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

To the Editor:

Hyperkalaemia is one of the most severe electrolyte disorders, especially in patients with chronic kidney disease (CKD) who are incapable of efficient renal potassium excretion.1-4

High potassium levels lead to changes in transmembrane potential of the cells of skeletal and cardiac muscles, the organs which are most clinically affected.1-4

In patients with pacemakers, hyperkalaemia can cause dysfunction of the device and therefore the patient’s life may be at risk.4,5

We report the case of a pacemaker malfunction due to hyperkalaemia in a patient with multiple risk factors for developing the aforementioned electrolyte disorder.

 

CASE REPORT

 

A 72-year-old female who came to the haemodialysis centre, after the long weekend interdialytic period, complaining of generalised muscle weakness, to the point that it prevented her from walking.

She had stage V CKD and had been on periodic haemodialysis for four years. She had a single chamber pacemaker due to chronic atrial fibrillation with symptomatic bradycardia (repeated syncope). Other history findings included type 2 diabetes mellitus treated with oral anti-diabetic medication, and high blood pressure. Her regular medication included omeprazole, amiodarone and aspirin (none of which affected on potassium homeostasis). Her adherence to medical treatment was poor and she often consumed unsuitable foods. Physical examination was unremarkable except for the aforementioned muscle weakness. The constants were correct and the patient was normoglycaemic. The electrocardiogram (ECG) showed a pacemaker rate, without any other abnormalities. The urgent analysis revealed potassium levels of 8.2mEq/l. While waiting for the haemodialysis session, she began conventional treatment for hyperkalaemia, with calcium gluconate, intravenous salbutamol and an infusion of insulin and glucose being administered.

Minutes after beginning this treatment, the patient experienced a sudden decrease in her level of consciousness, with undetectable blood pressure and signs of peripheral hypoperfusion. At that moment, the ECG showed failure of ventricular capture (Figure 1). Urgent haemodialysis was performed, with both symptoms and electrocardiographic abnormalities being quickly and completely reversed.

 

DISCUSSION

 

Severe hyperkalaemia is a common problem in patients with advanced CKD.1 It may affect 5%-10% of patients on chronic haemodialysis monthly. It may also require urgent haemodialysis in up to 24% of patients with end-stage CKD and it has a significant mortality rate.1

Potential causes of hyperkalaemia in patients such as ours are multifactorial and may include, in addition to CKD, metabolic acidosis, hyporeninemic hypoaldosteronism (common in diabetics), defects of cell Na+/K+-ATPase and poor diet1-3 (recognised by our patient).

In patients with cardiac pacemakers, hyperkalaemia can cause various types of dysfunction of the device, with very serious consequences.4,5 In our case, there was a failure of ventricular capture. In this situation, excess of extracellular potassium increases the resting potential of the myocardial cell membrane.4 If this potential exceeds the energy emitted by the pacemaker according to its programming, cardiac muscle cell depolarisation is inhibited. This situation is recognised in the ECG by the absence of depolarisation after the spicules. The clinical manifestation, which is clearly serious, is asystole.4,5

In conclusion, the presence of a cardiac pacemaker does not always protect the myocardium from the deleterious effects of hyperkalaemia. Moreover, the device requires a normal electrolyte balance for proper operation. Therefore, heart rate monitoring, which is essential for all symptomatic hyperkalaemia, should not be overlooked in patients with pacemakers. Likewise, the presence of a pacemaker must not be a decisive factor when urgent haemodialysis is indicated for severe hyperkalaemia.

 

Conflicts of interest

 

The authors declare that they have no conflicts of interest related to the contents of this article.

Figure 1. 12-lead electrocardiogram showing the failure of capture (absence of QRS complexes after the first, second and fourth spicules)

Bibliography
[1]
Putcha N, Allon M. Management of hyperkalemia in dialysis patients. Semin Dial 2007;20:431-9. [Pubmed]
[2]
Shingarev R, Allon M. A physiologic-based approach to the treatment of acute hyperkalemia. Am J Kidney Dis 2010;56:578-84. [Pubmed]
[3]
Palmer BF. A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis 2010;56:387-93. [Pubmed]
[4]
Kahloon MU, Aslam AK, Aslam AF, Wilbur SL, Vasavada BC, Khan IA. Hyperkalemia induced failure of atrial and ventricular pacemaker capture. Int J Cardiol 2005;105:224-6. [Pubmed]
[5]
Hayes DL, Vlietstra RE. Pacemaker malfunction. Ann Intern Med 1993;119:828-35. [Pubmed]
Idiomas
Nefrología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.